-
2201“…BACKGROUND: Cutaneous leishmaniasis (CL) is a vector-borne disease prevalent in Algeria since 2000. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2202por Shamsian, Seyed Aliakbar, Mirizadeh, Hamed, Salehi Sangani, Ghodratollah, Zarean, Mahdi, Berenji, Fariba, Najjari, Mohsen, Fata, Abdolmajid, Serki, Elham, Tahreian, Vahideh, Hosseini Farash, Bibi RaziehEnlace del recurso
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2203por Singh, Abhishek Kumar, de Gooyer, Tanyth, Singh, Om Prakash, Pandey, Sundaram, Neyaz, Aziza, Cloots, Kristien, Kansal, Sangeeta, Malaviya, Paritosh, Rai, Madhukar, Nylén, Susanne, Chakravarty, Jaya, Hasker, Epco, Sundar, Shyam“…The aims of the study were to assess the prevalence of filarial infection in asymptomatic Leishmania donovani infected individuals and the correlation of Wuchereria bancrofti infection with progression to clinical visceral leishmaniasis (VL) in Bihar, India. METHODOLOGY/PRINCIPAL FINDINGS: Within the Muzaffarpur-TMRC Health and Demographic Surveillance System (HDSS) area, a cohort of Leishmania seropositive (n = 476) or seronegative individuals (n = 1130) were sampled annually for three years for filarial infection and followed for progression to clinical VL. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2204por Reid, Emma, Deb, Rinki Michelle, Ali, Asgar, Singh, Rudra Pratap, Mishra, Prabhas Kumar, Shepherd, Josephine, Singh, Anand Mohan, Bharti, Aakanksha, Singh, Chandramani, Sharma, Sadhana, Coleman, Michael, Weetman, David“…Molecular surveillance of resistance is an increasingly important part of vector borne disease control programmes that utilise insecticides. The visceral leishmaniasis (VL) elimination programme in India uses indoor residual spraying (IRS) with the pyrethroid, alpha-cypermethrin to control Phlebotomus argentipes the vector of Leishmania donovani, the causative agent of VL. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2205por Bezemer, Jacob M., Merckx, Joanna, Freire Paspuel, Byron P., Calvopiña, Manuel, de Vries, Henry J. C., Schallig, Henk D. F. H., Leeflang, Mariska M. G., Dendukuri, Nandini“…BACKGROUND: Clinical and laboratory diagnosis of cutaneous leishmaniasis (CL) is hampered by under-ascertainment of direct microscopy. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2206por Lee, Sang Hun, Kang, Byunghyun, Kamenyeva, Olena, Ferreira, Tiago Rodrigues, Cho, Kyoungin, Khillan, Jaspal S., Kabat, Juraj, Kelsall, Brian L., Sacks, David L.Enlace del recurso
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2207por Leopoldo, Paulo TG, Machado, Paulo RL, Almeida, Roque P, Schriefer, Albert, Giudice, Angela, de Jesus, Amélia Ribeiro, Ho, John L, Guimarães, Luiz Henrique, Bacellar, Olívia, Carvalho, Edgar M“…BACKGROUND: Disseminated leishmaniasis is an emerging infectious disease, mostly due to L. braziliensis, which has clinical and histopathological features distinct from cutaneous leishmaniasis. …”
Publicado 2006
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2208“…BACKGROUND: Although Kabul city, Afghanistan, is currently the worldwide largest focus of cutaneous leishmaniasis (CL) with an estimated 67,500 cases, donor interest in CL has been comparatively poor because the disease is non-fatal. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2209por Giudice, Angela, Camada, Ilza, Leopoldo, Paulo TG, Pereira, Júlia MB, Riley, Lee W, Wilson, Mary E, Ho, John L, de Jesus, Amelia Ribeiro, Carvalho, Edgar M, Almeida, Roque P“…Parasites were isolated from patients with cutaneous, mucosal or disseminated leishmaniasis, and NO(• )resistance was correlated with clinical presentation. …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2210por Raguenaud, Marie-Eve, Jansson, Anna, Vanlerberghe, Veerle, Van der Auwera, Geert, Deborggraeve, Stijn, Dujardin, Jean-Claude, Orfanos, Giannos, Reid, Tony, Boelaert, Marleen“…BACKGROUND: There are few reports describing the epidemiology of visceral leishmaniasis (VL) in Somalia. Over the years 2002 to 2005, a yearly average of 140 patients were reported from the Huddur centre in Bakool region, whereas in 2006, this number rose to 1002 patients. …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2211
-
2212por Panaro, Maria A, Brandonisio, Olga, de Caprariis, Donato, Cavallo, Pasqua, Cianciulli, Antonia, Mitolo, Vincenzo, Otranto, Domenico“…BACKGROUND: Human and canine leishmaniasis (CanL) by Leishmania infantum is endemic in Italy, with a high percentage of infected asymptomatic animals. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2213“…BACKGROUND: High cost, poor compliance, and systemic toxicity have limited the use of pentavalent antimony compounds (SbV), the treatment of choice for cutaneous leishmaniasis (CL). Paromomycin (PR) has been developed as an alternative to SbV, but existing data are conflicting. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2214“…INTRODUCTION: American tegumentary leishmaniasis (ATL) represents one of the most important public health issues in the world. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2215“…Experimental leishmaniasis is widely used to study the effector functions of T helper cell subsets in vivo. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2216por González, Camila, Wang, Ophelia, Strutz, Stavana E., González-Salazar, Constantino, Sánchez-Cordero, Víctor, Sarkar, Sahotra“…In North America (México, United States, and Canada), leishmaniasis is a vector-borne disease that is autochthonous in México and Texas and has begun to expand its range northward. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2217por Brannigan, James A., Smith, Barbara A., Yu, Zhiyong, Brzozowski, Andrzej M., Hodgkinson, Michael R., Maroof, Asher, Price, Helen P., Meier, Franziska, Leatherbarrow, Robin J., Tate, Edward W., Smith, Deborah F., Wilkinson, Anthony J.“…These studies validate L. donovani NMT as a potential target for development of new therapeutic agents against visceral leishmaniasis.…”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2218“…BACKGROUND: Little information is available about infantile visceral leishmaniasis (VL) in Albania as regards incidence, diagnosis and management of the disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2219por Farouk, S., Salih, M.A., Musa, A.M., Blackwell, J.M., Miller, E.N., Khalil, E.A., ElHassan, A.M., Ibrahim, M.E., Mohamed, H.S.“…BACKGROUND: Post kala-azar dermal leishmaniasis (PKDL) is a cutaneous form of disease that develops at variable times after individuals have received treatment for clinical visceral leishmaniasis (VL). …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2220por Hailu, Asrat, Musa, Ahmed, Wasunna, Monique, Balasegaram, Manica, Yifru, Sisay, Mengistu, Getahun, Hurissa, Zewdu, Hailu, Workagegnehu, Weldegebreal, Teklu, Tesfaye, Samson, Makonnen, Eyasu, Khalil, Eltahir, Ahmed, Osama, Fadlalla, Ahmed, El-Hassan, Ahmed, Raheem, Muzamil, Mueller, Marius, Koummuki, Yousif, Rashid, Juma, Mbui, Jane, Mucee, Geoffrey, Njoroge, Simon, Manduku, Veronica, Musibi, Alice, Mutuma, Geoffrey, Kirui, Fredrick, Lodenyo, Hudson, Mutea, Dedan, Kirigi, George, Edwards, Tansy, Smith, Peter, Muthami, Lawrence, Royce, Catherine, Ellis, Sally, Alobo, Moses, Omollo, Raymond, Kesusu, Josephine, Owiti, Rhoda, Kinuthia, John“…BACKGROUND: Visceral leishmaniasis (VL) is a major health problem in developing countries. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto